Breakthrough

Recent breakthroughs in common adult leukemia highlighted in New England Journal of Medicine

When the most common adult leukemia in the United States was last reviewed by the New England Journal of Medicine (NEJM) in 1995, it was seen through the eyes of theories that dated back to the 1960s. As such, the journal recently invited three of the world's foremost experts on chronic lymphocytic leukemia (CLL) to write an authoritative update covering the transformation in the scientific commu...

Breakthrough Microarray-based Technology for the Study of Cancer

A new development in the analysis of cancerhas been announced by Agilent Technologies. The company has reported aninnovative method that enables the rapid advance of microarray-basedcomparative genomic studies in cancer. According to the reportpublished in the December 24, 2004 issue of the Proceedings of theNational Academy of Science (PNAS) in collaboration with the NationalHuman Genome R...

Leukemia Drug Breakthrough Study In New England Journal Of Medicine

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia. Given in pill form, Revlimid simultaneously blocks the growth of new blood vessels th...

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications. This groundbreaking research was recently featured in the leading Chemistry journal, Angewandte Chemie, and a United States patent has been filed on the inv...

MUHC researchers make cancer target breakthrough

Researchers at the McGill University Health Centre (MUHC), in Montreal, have identified a new gene to combat cancer. In a new study, published in the on-line edition of the journal Clinical Cancer Research this week, the researchers document a reduction in the growth of both colon and lung cancer tumors with inhibition of the gene. The new target gene is called methylenetetrahydrofolate re...

More>>

Breakthrough at Biology Products

No data found

Search Breakthrough biology products at Google

Search Breakthrough biology products at Yahoo

Search Breakthrough biology products at Msn

Breakthrough at Biology Technology

Stem cell breakthrough by UW shows why federal research should be broadened

If theres a positive side to the alleged research abuses in South Korea, it is the co...

Madison-based Mithridion seeks to capitalize on Alzheimer's breakthrough

Springing out of a promising research breakthrough on Alzheimer's disease, UW-Madison researcher Jeff Johnson has co-founded Mithridion Inc. in hopes of commercializing an Alzheimer's-inhibiting drug. Johnson and fellow researcher Thor Stein led a team that began about four years ago by asking a simple question: Why don't mouse neurons die when slammed by a protein thats been shown to ki...

Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment

Deltanoid founder and CEO Hector DeLuca has discovered and characterized a promising chemically modified Vitamin D compound, 2MD, which reverses the effects of osteoporosis. In animal studies, 2MD increases bone growth while leaving blood calcium levels unchanged even at doses 3,000 times the level of other compounds. According to DeLuca, Vitamin Ds main job is to regulate calcium level...

Breakthrough at Medicine News

Sperm washing helps couples – Breakthrough in focu

In many unfortunate instances we see couples who are HIV sero discordant but who would like to have a baby. If the husband is HIV –1 positive and the wife is negative and they are planning to have a child the problem arises because sexual intercourse carries a 1 in 500 risk of transmitting the virus to the female partner and through her to the fetus. Sperm washing is a risk-reduction option in wh...

ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer

Lung cancer, the header among all forms of cancer, is avenged now by the new proven effective ZD1839. It has been shown that ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, has confirmed, durable responses and safety in patients with advanced non-small cell lung cancer (NSCLC) as monotherapy and in combination with standard chemotherapy agents after segmental scrut...

Breakthrough in eye treatment

Millions of baby boomers and seniors are now using different sets of glasses to see and read far away or close up. Till now, the only alternative to glasses and contact lens, was laser surgery. Researchers at Mt. Sinai Medical Center, felt that this was a breakthrough - because it was a non-laser treatment for people who were far-sighted. //Conductive Kerato-plasty, or “CK”, is the first minimall...

Genetic Breakthrough in Common Eye Problem

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in the developed world. New research finds a genetic defect that could be involved with this disease. The discovery also helps // researchers understand the true complexity of this disease. Researchers collected blood samples from 402 people with AMD and 429 healthy individuals. The DNA was examined f...

Breakthrough in cancer therapy

Scientists have developed a way to stop the hair loss associated with drug treatment for cancer. This type of hair loss, known as chemotherapy-induced alopecia (CIA), is a frequent side effect of cancer therapy and is often very distressing for patients at a vulnerable time in their lives.// Currently, there is no effective way to stop this type of hair loss. The only way doctors can...

More>>

Breakthrough at Medicine Products

No data found

Search Breakthrough medicine products at Google

Search Breakthrough medicine products at Yahoo

Search Breakthrough medicine products at Msn

Breakthrough at Medicine Technology

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 10, 2007 - BusinessWeekpublished an article on July 6 discussing the race bypharmaceutical and biotechnology companies to be first to bring tomarket an effective angiogenesis treatment for cardiovasculardisease. While angiogenesis therapies are being pursued bySanofi-Aventis, Boston Scientific, Baxter, and Genzyme, amongothers, the article highlights a...

BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease

WAKEFIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - BusinessWeek todaypublished an article discussing the race by pharmaceutical andbiotechnology companies to be first to bring to market an effectiveangiogenesis treatment for cardiovascular disease. Whileangiogenesis therapies are being pursued by Sanofi-Aventis, BostonScientific, Baxter, and Genzyme, among others, the articlehighlights a very...

Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer

<p style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: 150%; mso-hyphenate: none">BUDAPEST, Hungary, June, 7, 2007--A pioneering nasal spraycould stop thousands of patients with cancer from sufferingunnecessary pain; it was reported today1 at the 10th Congress ofthe European Association for Palliative Care, Budapest, 7–9June. The study investigated whether this first in class novelformulation c...

Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference

PARIS--(BUSINESS WIRE)--May 31, 2007 - Hemispherx Biopharma, Inc.(AMEX: HEB), a biopharmaceutical company engaged in the clinicaldevelopment and manufacture of new drug entities for pandemicdisease threats, announced today a new scientific report featuringits antiviral therapeutic product candidate Alferon-LDO incombating highly pathogenic avian influenza (HPAI), also known as"bird flu." Al...

Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions

All Efficacy Measures Reached Statistical Significance FRAZER, Pa., May 01, 2007 /PRNewswire-FirstCall/ -- A Cephalon,Inc. Phase 3 clinical trial presented today at the 59th AnnualMeeting of the American Academy of Neurology in Boston highlightsdata demonstrating that FENTORA(R) (fentanyl buccal tablet) [C-II]is beneficial for the treatment of breakthrough pain in patientswith...

More>>